BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 27797769)

  • 1. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driver gene detection through Bayesian network integration of mutation and expression profiles.
    Chen Z; Lu Y; Cao B; Zhang W; Edwards A; Zhang K
    Bioinformatics; 2022 May; 38(10):2781-2790. PubMed ID: 35561191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based integration of multi-omics data for prioritizing cancer genes.
    Dimitrakopoulos C; Hindupur SK; Häfliger L; Behr J; Montazeri H; Hall MN; Beerenwinkel N
    Bioinformatics; 2018 Jul; 34(14):2441-2448. PubMed ID: 29547932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driver gene mutations based clustering of tumors: methods and applications.
    Zhang W; Flemington EK; Zhang K
    Bioinformatics; 2018 Jul; 34(13):i404-i411. PubMed ID: 29950003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
    Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
    Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian framework for de novo mutation calling in parents-offspring trios.
    Wei Q; Zhan X; Zhong X; Liu Y; Han Y; Chen W; Li B
    Bioinformatics; 2015 May; 31(9):1375-81. PubMed ID: 25535243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method.
    Amgalan B; Lee H
    Bioinformatics; 2015 Aug; 31(15):2452-60. PubMed ID: 25819079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
    Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
    Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
    Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian joint analysis of heterogeneous genomics data.
    Ray P; Zheng L; Lucas J; Carin L
    Bioinformatics; 2014 May; 30(10):1370-6. PubMed ID: 24489367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving existing analysis pipeline to identify and analyze cancer driver genes using multi-omics data.
    Nguyen QH; Le DH
    Sci Rep; 2020 Nov; 10(1):20521. PubMed ID: 33239644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
    PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
    Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
    BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MethCNA: a database for integrating genomic and epigenomic data in human cancer.
    Deng G; Yang J; Zhang Q; Xiao ZX; Cai H
    BMC Genomics; 2018 Feb; 19(1):138. PubMed ID: 29433427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes.
    Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
    Bioinformatics; 2013 Sep; 29(18):2238-44. PubMed ID: 23884480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
    Zhang W; Wang SL
    Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
    Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
    Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.